You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
OSI Systems reported revenue of $403 million and adjusted earnings per diluted share of $1.66 for its first quarter. It reaffirmed fiscal 2027 revenue guidance of $1.875 billion to $1.930 billion and raised non-GAAP EPS guidance to $11.28 to $11.64.
OSI Systems, Inc. reported Q1 fiscal 2027 net revenues of $403.5 million, up 4.9%, as Security and Optoelectronics and Manufacturing growth offset Healthcare’s decline. Gross profit increased to $123.8 million, but gross margin declined to 30.7% from 32.0%.
OSI Systems reported record Q1 fiscal 2027 revenues of $403 Million and GAAP EPS of $1.51, grew backlog to $2.1 Billion, reaffirmed revenue guidance of $1.875 billion - $1.930 billion, and raised non-GAAP EPS guidance to $11.28 - $11.64.
OSI Systems reported fiscal 2026 revenue of $1,786M, non-GAAP EPS of $10.35 and a record backlog of approximately $1.9 billion, despite delayed Security deliveries in the Middle East and a federal government shutdown.
Useful current figures from the complete screener profile.
TL;DR. OSI reported record Q1 revenue of $403 million, GAAP EPS of $1.51 and non-GAAP EPS of $1.66, more than doubled operating cash flow, expanded backlog to a record $2.1 billion, grew Opto, secured new CBP and RF contract activity, and expects free cash flow to exceed net income while raising fiscal 2027 non-GAAP EPS guidance and reaffirming revenue guidance. Gross and adjusted operating margins fell amid healthcare weakness and unfavorable mix, while Q2 revenue is expected to decline and geopolitical, government-funding, backlog-conversion and supply-chain risks remain.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Illustrative technical + ownership context — a signal mix, not investment advice.
| Metric | Latest | Period | YoY |
|---|---|---|---|
| Backlog | 1.9B | as of June 30, 2026 | — |
| Diluted earnings per share - non-GAAP non-GAAP | $10.35 | Fiscal Year 2026 | — |
| Shares repurchased | 564,880 | Three Months Ended June 30, 2026 | — |
| Stock repurchase program remaining authorization | 1,078,731 | As of August 20, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OSIS
this stock
Osi Systems Inc
|
$3.03B | -24.4% | +13.4% | 20.7 | 12.2% |
|
APH
Amphenol Corp
|
$193.17B | — | +51.7% | 34.1 | 1.1% |
|
GLW
Corning Inc
|
$98.27B | +30.3% | +19.1% | 46.4 | 1.9% |
|
TEL
TE Connectivity plc
|
$62.02B | -4.9% | +15.2% | 19.6 | 2.0% |
|
MRAAF
Murata Manufacturing Co., Ltd.
|
$57.31B | +41.0% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
OSI Systems, Inc. reported Q1 fiscal 2027 net revenues of $403.5 million, up 4.9%, as Security and Optoelectronics and Manufacturing growth offset Healthcare’s decline. Gross profit increased to $123.8 million, but gross margin declined to 30.7% from 32.0%.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OSIS | -1.8% | -1.1% | -12.7% | -3.3% | -24.4% |
| SPY | +2.6% | -1.2% | +0.5% | -0.2% | +10.6% |
| vs SPY | -4.3% | +0.1% | -13.2% | -3.1% | -35.0% |
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
